Floatz logo

CYCLOSPORIN A

Refractory Chronic Lymphocytic Leukemia

City of Hope Medical Centerprotein_peptidePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Refractory Chronic Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Benadryl
Institute of Hematology & Blood Diseases Hospital, China
Phase 2BBB
Flavopiridol
National Cancer Institute (NCI)
Phase 2BB
Therapeutic Allogeneic Lymphocytes
University of Chicago
Phase 2BB
Everolimus
OHSU Knight Cancer Institute
Phase 2BB
Nivolumab
M.D. Anderson Cancer Center
Phase 2BB

View all 32 →

Same molecule, other indications

CYCLOSPORIN A is also rated in:

non-Hodgkin lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Chronic Phase Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →